<DOC>
	<DOCNO>NCT03099876</DOCNO>
	<brief_summary>This study compare efficacy safety basic triple therapy accord treatment period . This study evaluate Effect CYP2C19 genetic polymorphism efficacy</brief_summary>
	<brief_title>A Study Eradication Rate Triple Therapy According Treatment Period CYP2C19 Polymorphisms H.Pylori Patients</brief_title>
	<detailed_description>This study compare efficacy safety basic triple therapy include Noltec ( Ilaprazole ) 10mg , Clapaxine ( Clarithromycin ) 500mg Pamoxin Cap ( Amoxicillin ) 1000mg BID first line eradication treatment H.pylori accord treatment period . Participants define person endoscopically confirm gastric duodenal ulcer ( include scar stage ) gastritis confirm H.pylori positive patient UBT test . For 7 day 10 day Participants treat basic triple therapy include Noltec ( Ilaprazole ) 10mg , Clapaxine ( Clarithromycin ) 500mg Pamoxin Cap ( Amoxicillin ) 1000mg BID . After treatment , The heal rate evaluate UBT test 49Â±5days first day dose . The investigator would point impact CYP2C19 genotypes Clarythromycin-based first-line rescue therapy .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Subject must endoscopically confirm gastric , duodenal ulcer ( include scar ) gastritis confirm H.pylori positive patient biopsy UBT test . Subject fully understand condition clinical trial . Subject agree participate spontaneously sign ICF Known hypersensitivity component ilaprazole , Amoxicillin Levofloxacin Subjects take contraindicated medication experimental concomitant drug . Patients abnormal level laboratory test Total Bilirubin , Creatinine &gt; 1.5 time upper limit normal AST , ALT , Alkaline phosphatase , BUN &gt; 2 time upper limit normal Administrated PPI , antibiotic medication within 4 week prior commencement study . Pregnant and/or lactate woman Reproductive age woman use contraception Uncontrolled diabetic Uncontrolled hypertension Uncontrolled liver dysfunction Alcoholics Subjects history digestive malignancy within 5 year Subjects history gastrectomy esophagectomy Subjects hereditary disease Galactose intolerance , Lapp lactose deficiency , glucosegalactose malabsorption . Subjects participate clinical trial another trial wihin 30 day Inconsistence judge subject researcher</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>